Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001932429 | SCV002135679 | benign | not provided | 2023-09-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002550392 | SCV003722751 | likely benign | Inborn genetic diseases | 2021-07-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004743612 | SCV005345970 | uncertain significance | RAI1-related disorder | 2024-03-13 | no assertion criteria provided | clinical testing | The RAI1 c.4817C>T variant is predicted to result in the amino acid substitution p.Ala1606Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0044% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |